Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus

Journal of Infection

Volumn 58, Issue 2, 2009, Pages 131-137

  Rodríguez Baño, Jesús ^a   Millán, Antonio B ^a   Domínguez, M Angeles ^b   Borraz, Carmen ^b   González, M Pau ^b   Almirante, Benito ^c   Cercenado, Emilia ^d   Padilla, Belén ^d   Pujol, Miquel ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Cross infections; Health care associated infections; Methicillin resistant Staphylococcus aureus; Mortality; Multicenter study; Outcome

Indexed keywords

AMINOGLYCOSIDE; CLINDAMYCIN; COTRIMOXAZOLE; POLYPEPTIDE ANTIBIOTIC AGENT;

ABDOMINAL INFECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; CANCER PATIENT; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME VARIABLE; PREDICTION; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SPAIN; STAPHYLOCOCCUS INFECTION; URINARY CATHETER;

AGED; ANTI-BACTERIAL AGENTS; COHORT STUDIES; CROSS INFECTION; FEMALE; HOSPITALS; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SPAIN; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 59649130465     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.11.003     Document Type: Article

References (28)

1. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. J Am Med Assoc 298 (2007) 1763-1771
2. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., and Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteraemia: a meta-analysis. Clin Infect Dis 36 (2003) 53-59
3. French G.L., Cheng A.F., Ling J.M., Mo P., and Donnan S. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect 15 (1990) 117-125
4. Jordens J.Z., Duckworth G.J., and Williams R.J. Production of "virulence factors" by epidemic methicillin-resistant Staphylococcus aureus in vitro. J Med Microbiol 30 (1989) 245-252
5. Roughmann M.C. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 160 (2000) 1001-1004
6. Lodise T.P., McKinnon P.S., Swiderski L., and Rybak M.J. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 36 (2003) 1418-1423
7. Kim S.H., Park W.B., Lee K.D., Kang C.I., Bang J.I., Kim H.B., et al. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 54 (2004) 489-497
8. Fang C.T., Shau W.Y., Hsueh P.R., Chen Y.C., Wang J.T., Hung C.C., et al. Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteremia: impact on the outcome. J Antimicrob Chemother 57 (2006) 511-519
9. Gómez J., García-Vázquez E., Baños R., Canteras M., Ruiz J., Baños V., et al. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis 26 (2007) 239-245
10. Soriano A., Marco G., Martínez J.A., Pisos E., Almela M., Dimova V.P., et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 46 (2008) 193-200
11. Schramm G.E., Johnson J.A., Doherty J.A., Micek S.T., and Kollef M.H. Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med 34 (2006) 2069-2074
12. Kim S.H., Kim K.H., Kim H.B., Kim N.J., Kim E.C., Oh M.D., et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 52 (2008) 192-197
13. Rodríguez-Baño J., Millán A.B., Domínguez M.A., Almirante B., Cercenado E., Padilla B., et al. Medidas de control de Staphylococcus aureus resistente a meticilina en hospitales españoles. Encuesta del proyecto SARM 2003 GEIH/GEMARA/REIPI. Enferm Infecc Microbiol Clin 24 (2006) 149-156
14. Rodríguez-Baño J, Domínguez MA, Millán AB, Borraz C, González MP, Almirante B, et al. Clinical and molecular epidemiology of community, health care-associated and nosocomial methicillin-resistant Staphylococus aureus in Spain. Clin Microbiol Infect 2008 (in press).
15. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method for classifying comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
16. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1998. Am J Infect Control 16 (1988) 128-140
17. Millar B.C., Loughrey A., Elborn J.S., and Moore J.E. Proposed definitions of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect 67 (2007) 109-113
18. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
19. Broseta A., Chaves F., Rojo P., and Otero J.R. Emergencia de un clon de Staphylococcus aureus resistente a meticilina de origen comunitario en la población pediátrica del sur de Madrid. Enferm Infecc Microbiol Clin 24 (2006) 31-35
20. Manzur A., Domínguez M.A., Pujol M., González M.P., Limón E., Hornero A., et al. Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect 14 (2008) 377-380
21. Cercenado E., Cuevas O., Marín M., Bouza E., Trincado P., Boquete T., et al. Community-acquired methicillin-resistant Staphylococcus aureus in Madrid, Spain: transcontinental importation and polyclonal emergence of Panton-Valentine leukocidin-positive isolates. Diagn Microbiol Infect Dis 61 (2008) 143-149
22. Bagley S.C., White H., and Golomb B.A. Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. J Clin Epidemiol 54 (2001) 979-985
23. Hidayat L.K., Hsu D.I., Quist R., Shriner K.A., and Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections. Arch Intern Med 166 (2006) 2138-2144
24. McDonald J.R., Friedman N.D., Stout J.E., Sexton D.J., and Kaye K.S. Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 165 (2005) 308-313
25. Safdar N., and Maki D.G. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136 (2002) 834-844
26. Pujol M., Peña C., Pallares R., Ariza J., Ayats J., Dominguez M.A., et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 100 (1996) 509-516
27. Davis K.A., Stewart J.J., Crouch H.K., Florez C.E., and Hospenthal D.R. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 39 (2004) 776-782
28. Robisek A., Beaumont J.L., Paule S.M., Hacek D.M., Thomson Jr. R.B., Kaul K.L., et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148 (2008) 409-418